Showing results (1301-1310 of 2,692) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|March 20, 2026
Na-GST-1 adsorbed on Alhydrogel co-administered with different Toll-like receptor agonists in hookworm-naive adults using a controlled human infection model in the USA: a phase 2, double-blind, randomised controlled trialCaroline K DiRosato, Elissa M Malkin, Sean M Lee, et al.
The Lancet. Infectious Diseases|March 19, 2026
Evaluating dengue transmission dynamics in an endemic urban setting in Viet Nam: an index-household contact cohort studyLucy Masdin, James Ashall, Mai Kim Huynh, et al.
The Lancet. Infectious Diseases|April 20, 2026
Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry studyAnnalisa Paviglianiti, Per Ljungman, Rafael de la Camara, et al.
The Lancet. Infectious Diseases|May 19, 2026
Global and regional molecular epidemiology of HIV-1 during 1990-2024: systematic review, global survey, and analysis of prevalenceAyisha Khalid, Lucy Gettins, Lauren Scullion, et al.
The Lancet. Infectious Diseases|May 11, 2026
Dihydroartemisinin-piperaquine versus chloroquine for the treatment of uncomplicated Plasmodium vivax malaria with concurrent or delayed high-dose primaquine in Brazil (Curavivax): an open-label, single-centre, randomised clinical trialDjane C Baía-da-Silva, Kim Vinícius AmaralC Machado, Amanda Lia RebêloC Rabelo, et al.
The Lancet. Infectious Diseases|October 28, 2006
Hookworm vaccines: past, present, and futureAlex Loukas, Jeffrey Bethony, Simon Brooker, et al.
The Lancet. Infectious Diseases|July 28, 2006
Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study designHannah B Ibanga, Roger H Brookes, Philip C Hill, et al.
The Lancet. Infectious Diseases|February 2, 2010
Serogroup B meningococcal vaccines-an unfinished storyManish Sadarangani, Andrew J Pollard
The Lancet. Infectious Diseases|June 9, 2026
Calciphylaxis complicated by NDM-1-producing Pseudomonas aeruginosa: first experience with cefepime-zidebactam alongside phage therapy in the USAErlinda R Ulloa, Daniel Jaffurs, M Tuan Tran, et al.
The Lancet. Infectious Diseases|June 1, 2026
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing developmentFrancesca Saluzzo, Seda Yerlikaya, Susan Elizabeth Dorman, et al.
Pageof 270